Hansoh Pharmaceutical Group Company Limited

3692.HK · Moat type: REGULIERUNG

MoatScore

10/10

Fair Value

50 HKD (≈ 6.41 USD)

Margin of Safety

+34.7 %

Rating

STARK

GESCHÄFTSMODELL Hansoh Pharmaceutical develops, manufactures, and markets prescription pharmaceuticals with a focus on oncology, psychiatry, and metabolic diseases, and secures its pricing power primarily through patent protection, regulatory approval barriers, and a growing portfolio of innovative active ingredients in the Chinese market.

View full analysis →

🔒 Detailed AI analysis, peer comparison, capital allocation, crisis resilience & PDF report for Pro members.

Not investment advice. Analyses are research, not a recommendation. Valuations may be erroneous or incomplete. © MoatScan.ai — proprietary methodology.